HomeBUSINESS
BUSINESS

Daiichi Sankyo Initiates AMED-Funded Joint Research on Genetic Vaccine Platform with NIBIOHN
(Oct.13.2017)

Daiichi Sankyo said on October 12 that it has initiated joint research with the National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) on the development of a genetic vaccine platform, utilizing its in-house developed novel nucleic acid delivery technology ...
(LOG IN FOR FULL STORY)

News Calendar